Publications by authors named "Tali Nir"

Claim this Profile
S
Sleep, Growth, and Puberty After 2 Years of Prolonged-Release Melatonin in Children With Autism Spectrum Disorder.
Beth A Malow, Robert L Findling, Carmen M Schroder, Athanasios Maras, John Breddy, Tali Nir

J Am Acad Child Adolesc Psychiatry· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Melatonin: From Pharmacokinetics to Clinical Use in Autism Spectrum Disorder.
Sébastien Lalanne, Claire Fougerou-Leurent, George M Anderson, Carmen M Schroder, Tali Nir

Int J Mol Sci· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pediatric Prolonged-Release Melatonin for Sleep in Children with Autism Spectrum Disorder: Impact on Child Behavior and Caregiver's Quality of Life.
Carmen M Schroder, Beth A Malow, Athanasios Maras, Raun D Melmed, Robert L Findling, Tali Nir

J Autism Dev Disord· August 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-Term Efficacy and Safety of Pediatric Prolonged-Release Melatonin for Insomnia in Children with Autism Spectrum Disorder.
Athanasios Maras, Carmen M Schroder, Beth A Malow, Robert L Findling, John Breddy, Tali Nir

J Child Adolesc Psychopharmacol· December 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and Safety of Pediatric Prolonged-Release Melatonin for Insomnia in Children With Autism Spectrum Disorder.
Paul Gringras, Tali Nir, John Breddy, Anat Frydman-Marom, Robert L Findling

J Am Acad Child Adolesc Psychiatry· November 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Add-on prolonged-release melatonin for cognitive function and sleep in mild to moderate Alzheimer's disease: a 6-month, randomized, placebo-controlled, multicenter trial.
Alan G Wade, Mildred Farmer, Gil Harari, Naama Fund, Moshe Laudon, Tali Nir

Clin Interv Aging· March 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prolonged release melatonin for improving sleep in totally blind subjects: a pilot placebo-controlled multicenter trial.
Thomas Roth, Tali Nir, Nava Zisapel

Nat Sci Sleep· February 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and safety of prolonged-release melatonin for insomnia in middle-aged and elderly patients with hypertension: a combined analysis of controlled clinical trials.
Patrick Lemoine, Alan G Wade, Amnon Katz, Tali Nir, Nava Zisapel

Integr Blood Press Control· October 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of prolonged-release melatonin and zolpidem on postural stability in older adults.
Sarah Otmani, Deborah Metzger, Nathalie Guichard, Philippe Danjou, Tali Nir

Hum Psychopharmacol· May 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prolonged-release melatonin for insomnia - an open-label long-term study of efficacy, safety, and withdrawal.
Patrick Lemoine, Doron Garfinkel, Moshe Laudon, Tali Nir, Nava Zisapel

Ther Clin Risk Manag· November 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prolonged release melatonin in the treatment of primary insomnia: evaluation of the age cut-off for short- and long-term response.
Alan G Wade, Gordon Crawford, Ian Ford, Alex McConnachie, Tali Nir

Curr Med Res Opin· January 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nightly treatment of primary insomnia with prolonged release melatonin for 6 months: a randomized placebo controlled trial on age and endogenous melatonin as predictors of efficacy and safety.
Alan G Wade, Ian Ford, Gordon Crawford, Alex McConnachie, Tali Nir

BMC Med· August 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prolonged-release melatonin improves sleep quality and morning alertness in insomnia patients aged 55 years and older and has no withdrawal effects.
Patrick Lemoine, Tali Nir, Moshe Laudon, Nava Zisapel

J Sleep Res· December 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy of prolonged release melatonin in insomnia patients aged 55-80 years: quality of sleep and next-day alertness outcomes.
Alan G Wade, Ian Ford, Gordon Crawford, Alex D McMahon, Tali Nir

Curr Med Res Opin· October 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Determination of the minimal clinically significant difference on a patient visual analog sleep quality scale.
Nava Zisapel, Tali Nir

J Sleep Res· December 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis